Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market

Novo Nordisk (NYSE: ) has launched blockbuster weight-loss drug Wegovy in Germany, its first big European market, hoping Germans will pay hundreds of euros out of pocket for a drug that public health insurance plans are so far barred from covering. The drug, shown to help patients reduce body…

#novonordisk #wegovy #germans #norway #denmark #novo #danish #allianz #etr #obese